节点文献

2008—2010年复旦大学附属肿瘤医院5-羟色胺3受体阻断剂临床应用分析

Utilization of 5-HT3 Receptor Antagonists in Fudan University Affiliated Tumor Hospital During 2008-2010

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 孙祎胡晓文

【Author】 SUN Yi,HU Xiao-wen(Dept.of Pharmacy,Fudan University Affiliated Tumor Hospital;Dept.of Oncology,Shanghai Medical College of Fudan University,Shanghai 200032,China)

【机构】 复旦大学附属肿瘤医院药剂科复旦大学上海医学院肿瘤学系

【摘要】 目的:统计我院2008—2010年临床5-羟色胺3(5-HT3)受体阻断剂使用情况和发展趋势,探讨合理使用要点。方法:对我院3年来5-HT3受体阻断剂使用情况进行回顾性分析,统计药品的销售数量、金额、类别,分析临床用药趋势。结果:5-HT3受体阻断剂总体用量呈快速增长,品种使用显示出明显的变化趋势。结论:3年来5-HT3受体阻断剂总体用量增长,长半衰期品种受临床欢迎。

【Abstract】 OBJECTIVE: To analyze the status quo and tendency of the utilization of 5-hydroxytryptamine type 3(5-HT3) receptor antagonists in our hospital during 2008-2010 and discuss the key points in the rational use of 5-HT3 receptor antagonist.METHODS: The utilization of 5-HT3 receptor antagonists in our hospital during 2008-2010 was analyzed statistically with regard to consumption amount,consumption sum,varieties and utilization tendency.RESULTS: During 2008-2010,the overall consumption amount of 5-HT3 receptor antagonists increased rapidly and its varieties assumed an evident variation tendency.CONCLUSION: The overall consumption amount of 5-HT3 receptor antagonists in our hospital during 2008-2010 increased and the 5-HT3 receptor antagonists with long half-life period are welcome clinically.

  • 【文献出处】 中国医院用药评价与分析 ,Evaluation and Analysis of Drug-Use in Hospitals of China , 编辑部邮箱 ,2012年02期
  • 【分类号】R96
  • 【被引频次】1
  • 【下载频次】177
节点文献中: 

本文链接的文献网络图示:

本文的引文网络